Smith & Nephew PLC
European stocks open higher on China-U.S. optimism
European stocks opened higher on Friday, as investors assessed a signal that China is seeking trade negotiations will the U.S. The Stoxx 600 index jumped 0.88% in early deals, led by mining stocks, up 2.5%, while banks climbed 1.7%. Most markets were closed on Thursday for the May 1 holiday. London’s FTSE 100 ended a choppy […]
Read More
These European stocks have the most to lose from Trump’s tariffs
European exporters to the U.S. may face significant headwinds from new tariffs President Donald Trump is expected to unveil Wednesday afternoon . While details remain scarce ahead of a Rose Garden ceremony at 4 p.m. ET, investors have been bracing themselves for broad-based levies on imports. Treasury Secretary Scott Bessent previously called out the “Dirty 15,” […]
Read More
European markets head for mixed open as lackluster sentiment spreads
European stocks are expected to open in mixed territory Tuesday as a lukewarm mood pervades global markets. The U.K.’s FTSE 100 index is expected to open unchanged at 8,637, Germany’s DAX down 29 points at 22,381, France’s CAC 2 points lower at 8,084 and Italy’s FTSE MIB 27 points higher at 38,542, according to data from […]
Read More
Activist Cevian has a stake in clinical system corporation Smith & Nephew. How it may help boost margins
A logo sign exterior of a facility occupied by Smith & Nephew in Austin, Texas. SIPPL Sipa United states | AP Organization: Smith & Nephew (SN.-GB) Organization: Smith & Nephew is a British portfolio professional medical technological innovation enterprise that operates globally. The enterprise develops, manufactures, markets and sells clinical equipment and providers. Its segments […]
Read More
Want to know where to invest for the next 10 years? Here’s what the pros suggest
Volatile markets, inflation hitting new highs and the risk of recession are making things tough for investors right now. “Looking out over the next 10 years, the forces that drove the rapid outperformance of growth over value are unlikely to repeat,” Paul Danis, head of asset allocation at Brewin Dolphin , told CNBC. “Bond yields […]
Read More